Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

被引:1316
作者
Milliez, P
Girerd, X
Plouin, PF
Blacher, J
Safar, ME
Mourad, JJ
机构
[1] Lariboisiere Hosp, Dept Cardiol, Paris, France
[2] Hop La Pitie Salpetriere, Dept Endocrinol, Paris, France
[3] Georges Pompidou Hosp, Dept Hypertens, Paris, France
[4] Hop Hotel Dieu, Diag Ctr, Paris, France
[5] Avicenne Hosp, Dept Internal Med, Bobigny, France
关键词
D O I
10.1016/j.jacc.2005.01.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this report was to show that the rate of cardiovascular events is increased in patients with either subtype of primary aldosteronism (PA). BACKGROUND Primary aldosteronism involves hypertension (HTN), hypokalemia, and low plasma renin. The two major PA subtypes are unilateral aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia. METHODS During a three-year period, the diagnosis of PA was made in 124 of 5,500 patients referred for comprehensive evaluation and management. Adenomas were diagnosed in 65 patients and idiopathic hyperaldosteronism in 59 patients. During the same period, clinical characteristics and cardiovascular events of this group were compared with those of 465 patients with essential hypertension (EHT) randomly matched for age, gender, and systolic and diastolic blood pressure. RESULTS A history, of stroke was found in 1.2.9% of patients with PA and 3.4% of patients with EHT (odds ratio [OR] = 4.2; 95% confidence interval [CI] 2.0 to 8.6]). Non-fatal myocardial infarction was diagnosed in 4.0% of patients with PA and in 0.6% of patients with EHT (OR = 6.5; 95% CI 1.5 to 27.4). A history, of atrial fibrillation was diagnosed in 7.3% of patients with PA and 0.6% of patients with EHT (OR = 12.1; 95% CI 3.2 to 45.2). The occurrence of cardiovascular complications was comparable in both subtypes of PA. CONCLUSIONS Patients presenting with PA experienced more cardiovascular events than did EHT patients independent of blood pressure. The presence of PA should be detected, not only to determine the cause of HTN, but also to prevent such complications.
引用
收藏
页码:1243 / 1248
页数:6
相关论文
共 44 条
[1]  
Abdo A, 1999, CAN J CARDIOL, V15, P347
[2]   Compensated cardiac hypertrophy: Arrhythmogenicity and the new myocardial phenotype .1. Fibrosis [J].
Assayag, P ;
Carre, F ;
Chevalier, B ;
Delcayre, C ;
Mansier, P ;
Swynghedauw, B .
CARDIOVASCULAR RESEARCH, 1997, 34 (03) :439-444
[3]   INDEPENDENT RISK-FACTORS FOR ATRIAL-FIBRILLATION IN A POPULATION-BASED COHORT - THE FRAMINGHAM HEART-STUDY [J].
BENJAMIN, EJ ;
LEVY, D ;
VAZIRI, SM ;
DAGOSTINO, RB ;
BELANGER, AJ ;
WOLF, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (11) :840-844
[4]   Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients [J].
Blacher, J ;
Asmar, R ;
Djane, S ;
London, GM ;
Safar, ME .
HYPERTENSION, 1999, 33 (05) :1111-1117
[5]   Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension [J].
Blacher, J ;
Amah, G ;
Girerd, X ;
Kheder, A ;
Ben Mais, H ;
London, GM ;
Safar, ME .
AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (12) :1326-1334
[6]   Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat [J].
Boixel, C ;
Fontaine, V ;
Rücker-Martin, C ;
Milliez, P ;
Louedec, L ;
Michel, JB ;
Jacob, MP ;
Hatem, SN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) :336-344
[7]   REACTIVE AND REPARATIVE MYOCARDIAL FIBROSIS IN ARTERIAL-HYPERTENSION IN THE RAT [J].
BRILLA, CG ;
WEBER, KT .
CARDIOVASCULAR RESEARCH, 1992, 26 (07) :671-677
[8]   Eplerenone - Cardiovascular protection [J].
Brown, NJ .
CIRCULATION, 2003, 107 (19) :2512-2518
[9]  
CLARKE D, 1979, LANCET, V1, P482
[10]   COMPUTER-ASSISTED TECHNIQUES FOR EVALUATION AND TREATMENT OF HYPERTENSIVE PATIENTS [J].
DEGOULET, P ;
CHATELLIER, G ;
DEVRIES, C ;
LAVRIL, M ;
MENARD, J .
AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (02) :156-163